$AQST 3 SEC Filings

Filed On	Filing
16 Oct 2026	Form 3: Daly Richard J, Director Holds 0 shares of Common Stock
10 Apr 2026	Form 3: Zalewski Thomas A., Chief Legal Officer Holds 0 shares of Common Stock
11 Mar 2026	Form 3: Greenhawt Matthew J., Chief Medical Officer Holds 2,000 shares of Common Stock
12 Nov 2025	Form 3: Davis Matthew W., Chief Development Officer No securities owned
07 May 2025	Form 3: Cioffi Melina, SVP Regulatory Affairs Holds 182,261 shares of Common Stock
11 Jun 2024	Form 3: Korczynski Sherry, SVP Sales and Marketing Holds 0 shares of Common Stock
26 Apr 2024	Form 3: Jenkins Abigail L., Director Holds 0 shares of Common Stock
30 Jun 2023	Form 3: Kraus Carl N, CHIEF MEDICAL OFFICER Holds 0 shares of Common Stock
11 Jan 2023	Form 3: Jung Cassie, SVP, Operations Holds 36,747 shares of Common Stock
11 Jan 2023	Form 3: Wargacki Stephen, SVP, Research & Development Holds 26,956 shares of Common Stock
22 Feb 2021	Form 3: Taglietti Marco, Director No securities owned
19 Feb 2021	Form 3: Krop Julie, Director No securities owned
08 Jan 2021	Form 3: Toth A Ernest Jr, Interim CFO No securities owned
07 Jan 2019	Form 3: Slatko Gary H, SVP, Chief Medical Officer No securities owned
13 Sep 2018	Form 3: Braender Lori J, SVP, General Counsel No securities owned
26 Jul 2018	Form 3: Monoline Partners, L.p., 10% owner Holds 165,000 shares of Common Stock
24 Jul 2018	Form 3: Wood Theresa, SVP-HR and Org. Development Holds 79,265 shares of Common Stock
24 Jul 2018	Form 3: Schobel Alexander Mark, Director Holds 1,000,000 shares of Common Stock
24 Jul 2018	Form 3: Marshall Ken W., Commercial Leader
24 Jul 2018	Form 3: Boyd Peter E., SVP-Operations/Value Delivery Holds 49,439 shares of Common Stock

Comments